CHEOY - CochLear Ltd ADR

NYSE * Healthcare * Medical Devices

$69.94

+$0.69 (+1.00%)

About CochLear Ltd ADR

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.

CHEOY Key Statistics

Market Cap

$9.15B

P/E Ratio

37.40

P/B Ratio

6.73

EPS

$1.87

Dividend Yield

0.06%

Revenue Growth

-0.0%

Profit Margin

0.1%

Employees

5,500

How CHEOY Compares to Peers

CHEOY ranks 2nd in profitability among competitors
CHEOY is the smallest among peers, which may offer higher growth potential

P/E Rank

#4

of 6

Margin Rank

#2

of 6

Growth Rank

#6

of 6

Size Rank

#6

of 6

CompanyP/EGrowthCompare
CHEOY37.4-0%-
ABT27.20%vs ABT
MDT24.30%vs MDT
SYK40.70%vs SYK
BSX33.30%vs BSX
ISRG59.70%vs ISRG

CochLear Ltd ADR Company Information

Headquarters
1 University Avenue, Sydney, NSW, Australia, 2109, undefined
Website
www.cochlear.com
Sector
Healthcare
Industry
Medical Devices
Data Updated:
Ready to invest in CHEOY?

Commission-free trading available. Affiliate links.

Upcoming Events for CHEOY